Daniel M. Junius, Director at IDEXX LABORATORIES INC /DE (IDXX), sold 5,366 shares at $506.41 ($2.7M) on 2025-05-13, disclosed to the SEC on 2025-05-14.
Seasonal sale ($2.7M) by Director — this insider has traded IDXX in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $506.41 | 2,683 | $1.4M | 50.0% |
| 2 | $506.41 | 2,683 | $1.4M | 50.0% |
| Total | $506.41 avg | 5,366 | $2.7M | 100% |
| Filing → |
| IDXX | SELL | 2022-12-07 | $2.6M | — | Filing → |
| GLYC | BUY | 2022-11-18 | $37K | — | Filing → |
| IDXX | SELL | 2021-08-12 | $3.3M | — | Filing → |